COCP (STOCKS)
Cocrystal Pharma, Inc. Common Stock
$1.390000
+0.140000 (+11.20%)
Prev close: $1.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sam Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $19.51M
- Employees
- 11
- P/E (TTM)
- -1.81
- P/B (TTM)
- 2.72
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.17 | $-0.18 | +0.0085 | +4.76% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.21 | +0.0242 | +11.30% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.31 | +0.1060 | +34.64% |
|
Mar 2025 (Q1)
|
$-0.23 | $-0.52 | +0.2851 | +55.35% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $188.00K |
| Operating Expenses | $9.02M |
| Depreciation and Amortization | $72.00K |
| Research and Development | $5.06M |
| Other Operating Expenses | $3.89M |
| Operating Income/Loss | -$9.02M |
| Income/Loss From Continuing Operations After Tax | -$8.83M |
| Income/Loss From Continuing Operations Before Tax | -$8.83M |
| Net Income/Loss | -$8.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.78 |
| Diluted Earnings Per Share | -$0.78 |
| Basic Average Shares | 11,290,000 |
| Diluted Average Shares | 11,290,000 |
| Assets | $9.71M |
| Current Assets | $8.13M |
| Noncurrent Assets | $1.58M |
| Fixed Assets | $93.00K |
| Other Non-current Assets | $1.49M |
| Liabilities | $3.38M |
| Current Liabilities | $2.21M |
| Accounts Payable | $890.00K |
| Wages | $85.00K |
| Other Current Liabilities | $1.24M |
| Noncurrent Liabilities | $1.17M |
| Equity | $6.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.33M |
| Liabilities And Equity | $9.71M |
| Net Cash Flow From Operating Activities | -$8.19M |
| Net Cash Flow From Operating Activities, Continuing | -$8.19M |
| Net Cash Flow From Investing Activities | -$12.00K |
| Net Cash Flow From Investing Activities, Continuing | -$12.00K |
| Net Cash Flow From Financing Activities | $8.20M |
| Net Cash Flow From Financing Activities, Continuing | $8.20M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$8.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.83M |
| Other Comprehensive Income/Loss | $0.00 |